Streetbeat News

Stock Prices

ALB

FMC

LPX

PCT

The article lists four oversold stocks in the materials sector that could potentially boost a portfolio. These include PureCycle Technologies, Inc. (NASDAQ:PCT), Albemarle Corporation (NYSE:ALB), FMC Corporation (NYSE:FMC), and Louisiana-Pacific Corporation (NYSE:LPX). All four companies have recently posted financial results, with PureCycle, FMC, and Louisiana-Pacific reporting losses, while Albemarle received a $90 million award from the U.S. Department of Defense.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 12:24 pm

ADBE

IEO

PSX

XLP

On CNBC's 'Halftime Report Final Trades', Josh Brown of Ritholtz Wealth Management recommended iShares U.S. Oil & Gas Exploration & Production ETF (IEO), Shannon Saccocia of Boston Private recommended Consumer Staples Select Sector SPDR Fund (XLP), Bill Baruch praised Adobe Inc. (ADBE) for its better-than-expected Q3 earnings, and Joseph Terranova of Virtus Investment Partners highlighted Phillips 66 (PSX) for its low earnings multiple and better-than-expected Q2 results.

Portfolio Pulse from Priya Nigam

September 26, 2023 | 12:20 pm

AKBA

Akebia Therapeutics has reduced its revenue guidance for its Auryxia product for FY23 from $175M-$180M to $170M-$175M. The revision is due to unfavorable market dynamics, volume, and payor mix.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:17 pm

AAL

DKNG

FLS

FREQ

IHS

NDSN

NKE

OLN

SITE

WING

WPC

Several analysts have updated their price targets and ratings for various US-listed companies. American Airlines, IHS Holding, Nordson Corporation, Olin Corporation, Frequency Therapeutics, W. P. Carey, and NIKE have seen their price targets cut, while Flowserve Corporation, SiteOne Landscape Supply, DraftKings, and Wingstop have seen their price targets raised. The stocks' reactions to these updates varied, with some seeing their share prices fall and others rise.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 12:13 pm

SNX

TD SYNNEX has projected its Q4 revenue to be between $14.0B and $15.0B, which is lower than the estimated $15.21B. The company also expects its adjusted EPS to be between $2.40 and $2.90, slightly below the estimated $2.95.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:10 pm

ICPT

Trading of Intercept Pharmaceuticals Inc (ICPT) shares is set to resume at 8:30 a.m. ET.

Portfolio Pulse from Bill Haddad

September 26, 2023 | 12:10 pm

SNX

TD Synnex (NYSE:SNX) reported Q3 adjusted earnings of $2.78 per share, beating the analyst consensus estimate of $2.48 by 12.1%. However, the company's quarterly sales of $13.96 billion missed the analyst consensus estimate of $14.11 billion by 1.06%. This represents a 9.09% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:06 pm

UNFI

United Natural Foods (UNFI) has provided its fiscal 2024 outlook, expecting net sales of $30.9B-$31.5B, adjusted EPS of $(0.88)-$0.38, and adjusted EBITDA of $450M-$550M. These figures are lower than the consensus estimates of $31.03B in net sales and $2.46 in adjusted EPS. The outlook reflects lower anticipated procurement gains due to moderating inflation and the restoration of performance-based incentive cash compensation.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:06 pm

MTN

JP Morgan analyst Brandt Montour maintains a Neutral rating on Vail Resorts (NYSE:MTN) and raises the price target from $231 to $280.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:04 pm

CADL

Candel Therapeutics has reported initial survival data from its Phase 2 clinical trial of CAN-2409 in non-small cell lung cancer. The initial data suggests that the 12-month survival is consistent with an increased tail on the maturing survival curve.

Portfolio Pulse from Bill Haddad

September 26, 2023 | 12:03 pm